Enhanced CIP2A expression is frequently overexpressed in non-small cell lung cancer (NSCLC) [6] and small cell lung cancer (SCLC) [7], where it promotes tumor progression. This evidence concerns the gene CIP2A and non-small cell lung carcinoma.